STAT1 and hepatocellular carcinoma: Importantly, RIG-I has previously been shown to enhance the IFN-α response in the absence of infection by amplifying IFN-α effector signaling via strengthening STAT1 activation in both in vitro and in vivo models of hepatocellular carcinoma.63